HighVista Strategies’s Quest Diagnostics DGX Stock Holding History

HighVista Strategies’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,800	Closed	-$233K	–	131
2018 Q4	$233K	Sell	2,800 -1,500	-35%	-$141K	0.2%	89
2018 Q3	$464K	Buy	4,300 +1,200	+39%	+$132K	0.22%	81
2018 Q2	$341K	Sell	3,100 -300	-9%	-$31.3K	0.15%	96
2018 Q1	$341K	Sell	3,400 -400	-11%	-$41K	0.15%	106
2017 Q4	$374K	Sell	3,800 -1,000	-21%	-$94.8K	0.1%	149
2017 Q3	$449K	Sell	4,800 -400	-8%	-$42.5K	0.1%	144
2017 Q2	$578K	Buy	+5,200	New	+$550K	0.13%	110

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighVista Strategies's DGX Position: Q1 2019 in Review

HighVista Strategies sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 2,800 shares — an estimated $233K sold.

HighVista Strategies first reported a position in DGX in Q2 2017 and held it in 7 quarters. The position peaked at $578K in Q2 2017. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

HighVista Strategies reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
HighVista Strategies sold 2,800 Quest Diagnostics shares in Q1 2019, an estimated $233K.
HighVista Strategies first reported a position in Quest Diagnostics in Q2 2017 and held it in 7 quarters.
HighVista Strategies's Quest Diagnostics position peaked at $578K in Q2 2017.
656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on HighVista Strategies's 13F filing for Q1 2019, filed 15 May 2019.